UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systematic screening versus clinical gestalt in the diagnosis of pulmonary embolism in COVID-19 patients in the emergency department

PloS one, 2023-03, Vol.18 (3), p.e0283459-e0283459

2023

Volltextzugriff (PDF)

Use of an algorithm based on routine blood laboratory tests to exclude COVID-19 in a screening-setting of healthcare workers

PloS one, 2022-06, Vol.17 (6), p.e0270548-e0270548

2022

Volltextzugriff (PDF)

Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis: A Randomized Controlled Trial

American journal of respiratory and critical care medicine, 2020-08, Vol.202 (3), p.393-401

2020

Volltextzugriff (PDF)

Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study

Annals of the rheumatic diseases, 2020-09, Vol.79 (9), p.1143-1151

2020

Volltextzugriff (PDF)

Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzer

Clinical chemistry and laboratory medicine, 2021-03, Vol.59 (4), p.783-793

2021

Volltextzugriff (PDF)

The use of online visual analogue scales in idiopathic pulmonary fibrosis

The European respiratory journal, 2022-01, Vol.59 (1), p.2101531

2022

Volltextzugriff (PDF)

When the Game Changes: Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 Pandemic

Chest, 2020-09, Vol.158 (3), p.892-895

2020

Volltextzugriff (PDF)

Aortic intramural haematoma associated with the use of nintedanib

British journal of clinical pharmacology, 2021-11, Vol.87 (11), p.4467-4469

2021

Volltextzugriff (PDF)

Systematic screening for pulmonary embolism using the YEARS algorithm in patients with suspected COVID-19 in the Emergency Department

Thrombosis research, 2021-11, Vol.207, p.113-115

2021

Volltextzugriff (PDF)

Invasive Pulmonary Aspergillosis with Marked Eosinophilia as a Unique Presentation of Chronic Granulomatous Disease

European journal of case reports in internal medicine, 2022-07, Vol.9 (7), p.003423-003423

2022

Volltextzugriff (PDF)

Single dose tocilizumab for COVID-19 associated cytokine storm syndrome: Less is more

British journal of clinical pharmacology, 2023-02

2023

Volltextzugriff (PDF)

Severe Fatigue is Highly Prevalent in Patients with IPF or Sarcoidosis

Journal of clinical medicine, 2020-04, Vol.9 (4), p.1178

2020

Volltextzugriff (PDF)

MPO-ANCA-associated vasculitis in the context of autoimmune polyglandular syndrome type 3: case report and literature review

Rheumatology advances in practice, 2022-12, Vol.6 (3)

2022

Volltextzugriff (PDF)

The laboratory parameters-derived CoLab score as an indicator of the host response in ICU COVID-19 patients decreases over time: a prospective cohort study

Scientific reports, 2024-04, Vol.14 (1), p.8220-8220, Article 8220

2024

Volltextzugriff (PDF)

Pulmonary embolism in hospitalized COVID-19 patients: Short- and long-term clinical outcomes

Thrombosis update, 2023-08, Vol.12, p.None-None, Article 100142

2023

Volltextzugriff (PDF)

Systematic screening versus clinical gestalt in the diagnosis of pulmonary embolism in COVID-19 patients in the emergency department

PloS one, 2023-03, Vol.18 (3), p.e0283459

2023

Volltextzugriff (PDF)

Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by Kaklamanos et al

Annals of the rheumatic diseases, 2023-06, Vol.82 (6), p.e135-e135

2023

Volltextzugriff (PDF)

Response to: ’Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by Charles

Annals of the rheumatic diseases, 2023-05, Vol.82 (5), p.e109-e109

2023

Volltextzugriff (PDF)

Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by De Santis et al

Annals of the rheumatic diseases, 2023-05, Vol.82 (5), p.e112-e112

2023

Volltextzugriff (PDF)

Casting light on the many facets of sarcoidosis

Current opinion in pulmonary medicine, 2023-09, Vol.29 (5), p.475-477

2023

Volltextzugriff (PDF)

Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study

Respiratory research, 2022-05, Vol.23 (1), p.139-139, Article 139

2022

Volltextzugriff (PDF)

Pulmonary Embolism in COVID-19: The Actual Prevalence Remains Unclear

Radiology, 2021-05, Vol.299 (2), p.E254-E254

2021

Volltextzugriff (PDF)

Daily home spirometry to detect early steroid treatment effects in newly treated pulmonary sarcoidosis

The European respiratory journal, 2018-01, Vol.51 (1), p.1702089-1702089

2018

Volltextzugriff (PDF)

Central diabetes insipidus due to sarcoidosis

Sarcoidosis, vasculitis, and diffuse lung diseases, 2017-01, Vol.34 (2), p.191-193

2017

Volltextzugriff (PDF)

Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study’’ by Calvo-Aranda et al

Annals of the rheumatic diseases, 2023-02, Vol.82 (2), p.e35-e35

2023

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(71)
Berichte
(3)

Sprache

Englisch
(71)
Niederländisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Systematic screening versus clinical gestalt in the diagnosis of pulmonary embolism in COVID-19 patients in the emergency department

Use of an algorithm based on routine blood laboratory tests to exclude COVID-19 in a screening-setting of healthcare workers

Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis: A Randomized Controlled Trial

Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study

Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzer

The use of online visual analogue scales in idiopathic pulmonary fibrosis

When the Game Changes: Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 Pandemic

Aortic intramural haematoma associated with the use of nintedanib

Systematic screening for pulmonary embolism using the YEARS algorithm in patients with suspected COVID-19 in the Emergency Department

Invasive Pulmonary Aspergillosis with Marked Eosinophilia as a Unique Presentation of Chronic Granulomatous Disease

Single dose tocilizumab for COVID-19 associated cytokine storm syndrome: Less is more

Severe Fatigue is Highly Prevalent in Patients with IPF or Sarcoidosis

MPO-ANCA-associated vasculitis in the context of autoimmune polyglandular syndrome type 3: case report and literature review

The laboratory parameters-derived CoLab score as an indicator of the host response in ICU COVID-19 patients decreases over time: a prospective cohort study

Pulmonary embolism in hospitalized COVID-19 patients: Short- and long-term clinical outcomes

Systematic screening versus clinical gestalt in the diagnosis of pulmonary embolism in COVID-19 patients in the emergency department

Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by Kaklamanos et al

Response to: ’Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by Charles

Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by De Santis et al

Casting light on the many facets of sarcoidosis

Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study

Pulmonary Embolism in COVID-19: The Actual Prevalence Remains Unclear

Daily home spirometry to detect early steroid treatment effects in newly treated pulmonary sarcoidosis

Central diabetes insipidus due to sarcoidosis

Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study’’ by Calvo-Aranda et al

Suchergebnisse filtern